Glatiramer Acetate Injection, Solution
Product Images NDC 82983-430
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Glatiramer Acetate (NDC 82983-430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ajenat Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure C (Fig C)
This is a description of areas to avoid when applying a product or treatment on the body. It specifies that one should avoid areas such as the back of hips and arms, about 2 inches around the fleshy areas of the upper hips, the belly button below the waist, fleshy areas of the upper back portion, arms, thighs, 2 inches above the knee, and 2 inches below the groin.*
Figure D (Fig D)
Figure E1 (Fig E1)
Figure E2 (Fig E2)
Figure E3 (Fig E3)
Figure F (Fig F)
Figure G (Fig G)
Figure H (Fig H)
Figure I (Fig I)
Figure J (Fig J)
Figure K (Fig K)
Figure L (Fig L.png)
Blister Label (Blister Packs 40mg)
This is a description of a prescription medication product called Glatiramer Acetate Injection, distributed by Ajenat Pharmaceuticals, LLC. Each pre-filled syringe contains 1mL of Glatiramer Acetate Injection with the active ingredient Glatiramer acetate 40 mg and the inactive ingredient mannitol 40 mg. The medication is intended for subcutaneous injection only and is to be taken three times a week. It is important to store this medication refrigerated at temperatures between 36°F to 46°F (2°C to 8°C) and protect it from light.*
Carton Label (Carton 40mg 260205)
Figure 1 (Fig 1)
Figure 2 (Fig 2)
Figure A (Fig A)
Syringe Label (Label For 40mg 260119)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.